摘要
目的分析替格瑞洛药物治疗急性冠脉综合征患者的临床作用。方法选取2015年12月—2016年12月的100例急性冠脉综合征患者作为研究对象,随机分2组,每组50例,观察组给予替格瑞洛药物治疗、对照组给予组氯吡格雷药物治疗,探究两组急性冠脉综合征疾病患者的不良心血管事件(MACE)发生情况和并发症发生情况。结果观察组MACE发生情况较对照组降低,并发症发生率减少(P<0.05)。结论替格瑞洛药物治疗急性冠脉综合征疾病能降低患者并发症情况。
Objective To analyze the clinical effects of ticagrelor in the treatment of acute coronary syndromes in patients with acute coronary syndrome.Methods From December 2015 to December 2016,100 patients with acute coronary syndrome were selected as the subjects,they were randomly divided into 2 groups,50 cases in each group,observation group was treated the treatment of ticagrelor,control group was treated with clopidogrel,incidence of adverse cardiovascular events（MACE） and complications in two groups of patients with acute coronary syndromeswere investigated.Results The incidence of MACE in the observation group was lower than that in the control group,and the complication rate was decreased（P〈0.05）.Conclusion The ticagrelor treatment of acute coronary syndrome with the use of the drugs reduces the patient＇s complications.
出处
《中国继续医学教育》
2017年第20期170-172,共3页
China Continuing Medical Education
